LIFEPharma announces AED 700 million KEZAD manufacturing platform at Make it in the Emirates 2026  The UAE’s only USFDA-approved pharmaceutical manufacturer, it signed a strategic agreement with AD Ports and unveiled plans to expand into vaccines, oncology, and advanced injectables Abu Dhabi, 4 May 2026:  LIFEPharma, the UAE’s only USFDA-approved pharmaceutical manufacturer and part of … Continue reading LIFEPharma announces AED 700 million KEZAD manufacturing platform at Make it in the Emirates 2026